Trials / Conditions / Primary Hyperoxaluria Type 3
Primary Hyperoxaluria Type 3
5 registered clinical trials studyying Primary Hyperoxaluria Type 3 — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Evaluation of the Efficacy and Safety of Stiripentol in Patients 6 Years and Older With Primary Hyperoxaluria NCT06465472 | Biocodex | Phase 3 |
| Completed | Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function NCT05001269 | Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | Phase 2 |
| Completed | Natural History of Patients With PH3 and a History of Stone Events NCT04542590 | Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | — |
| Completed | Study to Evaluate Safety, Tolerability, PK and PD of DCR-PHXC in PH Type 3 Patients NCT04555486 | Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | Phase 1 |
| Enrolling By Invitation | Early Check: Expanded Screening in Newborns NCT03655223 | RTI International | — |